CRDO — Trade Construction
Analysis only. This memo issues no position verdict — the book decides whether any of this is taken. Spot $192.28 (2026-07-28 close). As of 2026-07-29.
1. What the trade would be expressing
Not "AI infrastructure is big." The specific, falsifiable proposition is:
Credo's optical business reaches the >$500m FY2027 target management stated on 2026-04-13, diluting the concentration risk that currently caps the multiple, while AEC holds at a mid-single-digit sequential rate — and the market re-rates a $2.1bn-revenue, 33%-operating-margin business off a multiple that has already compressed to the 14th percentile of its own trailing twelve months.
It is refuted by any of: a fourth quarter of sub-8% sequential growth with no optical contribution disclosed; days-of-inventory above ~180; or a change in the customer-concentration table showing one of D/B/E stepping down.
2. Equity liquidity — PASS, trivially
| Measure | Value |
|---|---|
| 60-day average dollar volume | $1,881m/day |
| 20-day average dollar volume | $1,487m/day |
| 60-day average share volume | 8.22m shares/day |
| Market cap (186.5m × $192.28) | $35.86bn |
| Reported public float (10-K cover, 2025-10-31) | $30.0bn |
Any position this book would take is a fraction of a percent of one day's volume. Exit is not a constraint.
3. The options chain — pulled before anything was proposed
The Liquidity Criteria requires the actual chain first. It was pulled, and it disqualified the expiry that
matched the horizon. Source: Alpaca paper-api/v2/options/contracts for discovery and
data.alpaca.markets/v1beta1/options/snapshots for quotes and Greeks, 2026-07-29.
3.1 January 2027 (expiry 2027-01-15) — investable
| Strike | Type | Open interest | Bid | Ask | Bid size | Ask size | IV | Delta |
|---|---|---|---|---|---|---|---|---|
| 180 | call | 1,551 | 54.78 | 59.23 | 430 | 102 | 108.2% | 0.669 |
| 200 | call | 3,397 | 48.65 | 51.68 | 430 | 167 | 108.5% | 0.617 |
| 220 | call | 743 | 41.37 | 45.74 | 435 | 118 | 107.3% | 0.564 |
| 250 | call | 721 | 34.76 | 40.25 | 277 | 235 | 110.2% | 0.503 |
| 300 | call | 776 | 26.42 | 28.53 | 118 | 92 | 109.0% | 0.403 |
| 320 | call | 1,992 | 23.05 | 28.40 | 203 | 395 | 111.5% | 0.379 |
| 150 | put | 1,402 | 30.79 | 33.43 | 305 | 118 | 111.2% | −0.246 |
| 130 | put | 938 | 21.37 | 24.68 | 229 | 158 | 112.9% | −0.191 |
| 100 | put | 1,460 | 10.68 | 12.87 | 199 | 151 | 114.5% | −0.114 |
Open interest in the hundreds-to-thousands and quoted size of 100–435 contracts. This chain can be filled.
3.2 June 2027 (expiry 2027-06-17) — NOT investable
| Strike | Type | Open interest | Bid | Ask | Spread as % of mid |
|---|---|---|---|---|---|
| 150 | call | 7 | 83.63 | 90.62 | 8.0% |
| 190 | call | 17 | 70.07 | 74.26 | 5.8% |
| 200 | call | 28 | 65.64 | 72.57 | 10.0% |
| 250 | call | 78 | 53.37 | 61.15 | 13.6% |
| 290 | call | 26 | 44.38 | 52.86 | 17.4% |
Maximum open interest across every strike examined on this expiry is 78 contracts. This is the HCA failure mode exactly — an 18-contract chain that nothing tested for. The 12-month-matched expiry is uninvestable and no structure is proposed on it. Any option expression of this thesis must use January 2027 and accept a 5.6-month horizon against a 12-month target, which is a real mismatch and is stated as one rather than papered over.
3.3 Implied vs realised volatility — options are expensive here
| Value | |
|---|---|
| 252-day realised volatility | 90.7% |
| Implied volatility, Jan-2027 chain | 105–115%, clustered ~108–110% |
| Premium | ~+17 to +20 vol points |
Long-premium structures are paying a substantial spread over realised. That is the single most important input into vehicle choice below and it argues against buying naked calls.
4. Vehicle assessment
| Vehicle | Assessment |
|---|---|
| Common stock | The default and the recommended vehicle if a position is taken. No premium decay against a 108-vol option market; no expiry mismatch against a 12-month thesis whose decisive catalyst (Q1 FY2027) is ~5 weeks away; unlimited holding period through a possible air pocket, which matters because the FY2024 precedent recovered rather than impaired. Position sizing does the risk control, per the inverse-volatility protocol. |
| Long Jan-2027 calls | Buys a 108-vol option on a name with 91-vol realised, and expires 5.6 months into a 12-month thesis. Negative carry against a thesis whose evidence arrives on a quarterly cadence. Not recommended. |
| Jan-2027 call spread (e.g. 200/300) | Reduces the vol premium paid by selling the far wing, and both legs are liquid (OI 3,397 and 776; quoted size 118–430). Debit at mid ≈ $50.17 − $27.48 = $22.69, max value $100, so ~3.4:1 gross. Caps upside at $300 — below the bull target of $376. Defensible if the book wants defined risk, but the expiry mismatch remains. |
| Jan-2027 puts as a hedge (150 or 130 strike) | Both liquid (OI 1,402 / 938). Buys protection against precisely the named downside cause at ~112 vol. Expensive, but this is the one place where paying above realised is coherent — the risk is a jump on an earnings print, and realised vol understates jump risk by construction. |
| June-2027 anything | Disqualified on liquidity (§3.2). |
| Short / relative value | Short Mechanism Criteria fires on both legs (decelerating growth + margin runway contracting) — logged for the RV fork. A CRDO-vs-ALAB pair is the obvious construction given ALAB trades at ~1.7x CRDO's multiple while growing sequentially ~2x as fast; that comparison argues for long CRDO in the pair, not short. Nothing on the long-only fork acts on this. |
Vehicle conclusion: common stock. If defined risk is required, the Jan-2027 200/300 call spread is the only structure that clears the liquidity test — with its 5.6-month expiry stated as a known mismatch against the 12-month horizon.
5. Sizing inputs
Provided for the book; the memo does not set a size.
| Input | Value |
|---|---|
| 252-day realised volatility | 90.7% |
| Implied volatility (Jan-2027) | ~108% |
| Beta to hyperscaler-capex factor | Not computed; assume high — see correlation note below |
| 52-week range | $87.81 – $302.52 |
| Drawdown from 52-week high | −36.4% |
| Within-year peak-to-trough drawdowns | −39% (2022), −62% (2023), −33% (2024), −61% (2025), −46% (2026 YTD) |
| Bear target | $123 (−36.3%); tail case $89 (−54%) |
| Base target | $238 (+23.6%) |
| Bull target | $376 (+95.8%) |
Inverse-volatility sizing will size this name down hard, and that is correct. A name with a 62% realised drawdown in each of two of the last four calendar years, three customers at 84% of revenue and $31.9m of backlog should not carry a full slot.
Correlation warning — this is the material one for the book. CRDO's revenue driver is hyperscaler AI capex, which is the identical single factor driving NBIS, MU, SNDK, AMZN, MSFT, META and GOOGL already in this corpus. A CRDO position adds concentration to that factor, it does not diversify it. If the book is already at its limit on AI-infrastructure exposure, that constraint binds before any of the analysis above matters.
6. Entry and monitoring
Entry. Momentum Criteria is MEASURED and governs timing, not admission. The reading is mixed and deteriorating: 12-1 momentum +135.1% (top decile cross-sectionally) but −19.2% over the last month, with the reversal coincident with the Q4 sequential-growth break. The market is already repricing the finding this memo makes. Two coherent readings:
- Wait for the Q1 FY2027 print (~early September 2026, not company-confirmed). It resolves the single largest uncertainty — whether mid-single-digit sequential is a floor or a way-station — at the cost of giving up the move.
- Scale in ahead of it on the view that a 36% drawdown already discounts a deceleration that management pre-announced five months ago.
The memo does not choose. It notes that the catalyst is close, dense and binary, which argues for either a small pre-print position or none.
Invalidation triggers — any one of these breaks the thesis as written:
- Q1 FY2027 revenue below the $465m guidance floor.
- A fourth consecutive quarter of sub-8% sequential growth with no disclosed optical revenue contribution.
- Days of inventory above ~180 (currently 164, up 16 sequentially).
- Any FY2027 10-Q showing a top-three customer stepping down materially in the concentration table.
- The ">$500m optical revenue in fiscal 2027" target being withdrawn, deferred or quietly not repeated.
- GAAP operating margin below 28% for two consecutive quarters (Q1 FY2027 is guided to ~31.9%).
Confirmation triggers:
- Optical revenue disclosed and tracking to the $500m FY2027 target.
- Sequential growth re-accelerating above 10% on an optical contribution.
- A fourth material end customer appearing in the concentration table (concentration falling, not just rotating).
- Days of inventory falling back below 150.
7. Ledger entry — pre-registered before the outcome is known
Per references/recommendation-ledger.md. No specific contract is being recommended, so no trade line is
appended to trade_recommendations.jsonl. What is pre-registered is the analytic call, for scoring:
| Field | Value |
|---|---|
| Ticker | CRDO |
| Date | 2026-07-29 |
| Spot | $192.28 |
| 12-month target | $238 (+23.6%) |
| Bear / bull | $123 (−36.3%) / $376 (+95.8%) |
| Implied-path required CAGR | 45.2% (range 34–58%) |
| Demonstrated (trailing 3y) | 93.5% |
| Demonstrated (current run-rate) | 33.8% |
| Margin on trailing basis | +48.3pp |
| Margin on run-rate basis | −11.4pp |
| Bear-case cause | Demand pause / inventory correction at one of three end customers (84% of revenue) |
| Bear-case probability | 30% within eight quarters |
| Vehicle if taken | Common stock; Jan-2027 200/300 call spread if defined risk required |
| Disqualified vehicle | Any June-2027 option — max OI 78 contracts |
The pre-registered falsifiable claim, for the record: FY2027 revenue lands between $1.72bn and $2.25bn, and Credo discloses optical revenue as a separate line or a stated figure at least once during FY2027. Both are checkable within four quarters.